These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25520087)

  • 1. Exploring factors related to metastasis free survival in breast cancer patients using Bayesian cure models.
    Jafari-Koshki T; Mansourian M; Mokarian F
    Asian Pac J Cancer Prev; 2014; 15(22):9673-8. PubMed ID: 25520087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Affecting Long-Survival of Patients with Breast Cancer by Non-Mixture and Mixture Cure Models Using the Weibull, Log-logistic and Dagum Distributions: A Bayesian Approach.
    Rafati S; Baneshi MR; Bahrampour A
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):485-490. PubMed ID: 32102528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a Non-Mixture Cure Rate Model for Analyzing Survival of Patients with Breast Cancer.
    Baghestani AR; Moghaddam SS; Majd HA; Akbari ME; Nafissi N; Gohari K
    Asian Pac J Cancer Prev; 2015; 16(16):7359-63. PubMed ID: 26514537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the cure rate in Iranian breast cancer patients.
    Rahimzadeh M; Baghestani AR; Gohari MR; Pourhoseingholi MA
    Asian Pac J Cancer Prev; 2014; 15(12):4839-42. PubMed ID: 24998549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fitting Cure Rate Model to Breast Cancer Data of Cancer Research Center.
    Baghestani AR; Zayeri F; Akbari ME; Shojaee L; Khadembashi N; Shahmirzalou P
    Asian Pac J Cancer Prev; 2015; 16(17):7923-7. PubMed ID: 26625822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cure models for estimating hospital-based breast cancer survival.
    Rama R; Swaminathan R; Venkatesan P
    Asian Pac J Cancer Prev; 2010; 11(2):387-91. PubMed ID: 20843121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data.
    Baghestani AR; Shahmirzalou P; Sayad S; Akbari ME; Zayeri F
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1601-1606. PubMed ID: 29936785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Analysis of Patients with Breast Cancer using Weibull Parametric Model.
    Baghestani AR; Moghaddam SS; Majd HA; Akbari ME; Nafissi N; Gohari K
    Asian Pac J Cancer Prev; 2015; 16(18):8567-71. PubMed ID: 26745118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience.
    Houzé de l'Aulnoit A; Rogoz B; Pinçon C; Houzé de l'Aulnoit D
    Breast; 2018 Feb; 37():80-88. PubMed ID: 29102782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer-A Single Institution Experience.
    Rogoz B; Houzé de l'Aulnoit A; Duhamel A; Houzé de l'Aulnoit D
    Clin Breast Cancer; 2018 Jun; 18(3):246-253. PubMed ID: 28988656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Peer PG; Tjan-Heijnen VC
    Br J Cancer; 2015 Apr; 112(9):1445-51. PubMed ID: 25880008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
    Shigematsu H; Nishina M; Yasui D; Hirata T; Ozaki S
    World J Surg Oncol; 2019 Feb; 17(1):41. PubMed ID: 30797231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age related influence of triple receptor status on metastatic breast cancer post relapse survival.
    Todorovic-Rakovic N; Neskovic-Konstantinovic Z
    J BUON; 2013; 18(4):851-8. PubMed ID: 24344008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.
    Altundag K; Bondy ML; Mirza NQ; Kau SW; Broglio K; Hortobagyi GN; Rivera E
    Cancer; 2007 Dec; 110(12):2640-7. PubMed ID: 17960791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.